Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
BGI-Shenzhen, Shenzhen, China.
J Exp Med. 2021 Feb 1;218(2). doi: 10.1084/jem.20200573.
Both somatic hypermutation (SHM) and class switch recombination (CSR) are initiated by activation-induced cytidine deaminase (AID). Dysregulation of these processes has been linked to B cell lymphomagenesis. Here we performed an in-depth analysis of diffuse large B cell lymphoma (DLBCL) and follicular lymphoma (FL) genomes. We characterized seven genomic mutational signatures, including two B cell tumor-specific signatures, one of which is novel and associated with aberrant SHM. We further identified two major mutational signatures (K1 and K2) of clustered mutations (kataegis) resulting from the activities of AID or error-prone DNA polymerase η, respectively. K1 was associated with the immunoglobulin (Ig) switch region mutations/translocations and the ABC subtype of DLBCL, whereas K2 was related to the Ig variable region mutations and the GCB subtype of DLBCL and FL. Similar patterns were also observed in chronic lymphocytic leukemia subtypes. Thus, alterations associated with aberrant CSR and SHM activities can be linked to distinct developmental paths for different subtypes of B cell lymphomas.
体细胞超突变(SHM)和类别转换重组(CSR)均由激活诱导胞苷脱氨酶(AID)引发。这些过程的失调与 B 细胞淋巴瘤的发生有关。在这里,我们对弥漫性大 B 细胞淋巴瘤(DLBCL)和滤泡性淋巴瘤(FL)的基因组进行了深入分析。我们对 7 种基因组突变特征进行了描述,包括 2 种 B 细胞肿瘤特异性特征,其中 1 种是新颖的,与异常 SHM 相关。我们还分别确定了由 AID 或易错 DNA 聚合酶 η 活性引起的聚集突变(kataegis)的两个主要突变特征(K1 和 K2)。K1 与免疫球蛋白(Ig)开关区突变/易位和 DLBCL 的 ABC 亚型有关,而 K2 与 Ig 可变区突变和 DLBCL 和 FL 的 GCB 亚型有关。在慢性淋巴细胞白血病亚型中也观察到类似的模式。因此,与异常 CSR 和 SHM 活性相关的改变可以与不同 B 细胞淋巴瘤亚型的不同发育途径相关联。